双胎妊娠中基于体格检查指征的宫颈环扎术:一项随机对照试验
这项多中心随机对照试验纳入34例妊娠16周0/7天至23周6/7天、无症状宫颈扩张1至5厘米的双胎妊娠妇女,比较基于体格检查指征的宫颈环扎术与不环扎。因环扎组围产期死亡率显著降低,试验经中期分析后提前终止。环扎联合吲哚美辛和抗生素显著降低了各评估孕周的早产率及围产期死亡率。
要点
- 双胎妊娠无症状宫颈扩张者,环扎组<34周早产风险比为0.71(95%CI 0.52-0.96)。
- 环扎组围产期死亡率17.6% vs 不环扎组77%(RR 0.22,95%CI 0.1-0.5)。
- 环扎组平均分娩孕周29.05±1.7周 vs 不环扎组22.5±3.9周(P<.01)。
核心结论
- 在24周前无症状宫颈扩张的双胎妊娠妇女中,基于体格检查指征的宫颈环扎术联合吲哚美辛和抗生素显著降低了所有评估孕周的早产率。
- 环扎术使<28周早期早产风险降低约50%,围产期死亡率降低约78%。
研究设计与样本
- 多中心、平行组、开放标签、随机对照试验,2015年7月至2019年7月在8个中心入组。
- 纳入标准为双胎妊娠、妊娠16周0/7天至23周6/7天、无症状宫颈扩张1至5厘米。
- 排除单绒毛膜单羊膜囊双胎、选择性胎儿生长受限、双胎输血综合征、重大胎儿畸形、已知遗传异常、前置胎盘、临产征象或临床绒毛膜羊膜炎。
- 按1:1随机分为环扎组或不环扎组,采用意向性分析。
- 共随机34例,因知情同意过期排除4例,环扎组17例、不环扎组13例。
主要发现
- <34周早产:环扎组17例中12例(70%)vs 不环扎组13例中13例(100%)(RR 0.71,95%CI 0.52-0.96)。
- <32周早产:环扎组17例中11例(64.7%)vs 不环扎组13例中13例(100%)(RR 0.65,95%CI 0.46-0.92)。
- <28周早产:环扎组17例中7例(41%)vs 不环扎组13例中11例(84%)(RR 0.49,95%CI 0.26-0.89)。
- <24周早产:环扎组17例中5例(30%)vs 不环扎组13例中11例(84%)(RR 0.35,95%CI 0.16-0.75)。
- 平均分娩孕周:环扎组29.05±1.7周 vs 不环扎组22.5±3.9周(P<.01);诊断宫颈扩张至分娩平均间隔:环扎组8.3±5.8周 vs 不环扎组2.9±3.0周(P=.02)。
关键数值与推荐
- 环扎组所有妇女同时接受吲哚美辛和抗生素治疗。
- 环扎组17例中4例未接受手术操作,不环扎组无一例接受环扎。
- 数据与安全监察委员会因环扎组围产期死亡率显著降低而建议提前终止试验。
临床怎么用
- 对于24周前无症状宫颈扩张1至5厘米的双胎妊娠妇女,基于体格检查指征的宫颈环扎术联合吲哚美辛和抗生素可显著降低早产及围产期死亡率。
- 原文未据此给出推荐。
局限性
- 试验经中期分析后提前终止,共随机34例,因知情同意过期排除4例,最终环扎组17例、不环扎组13例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with twin pregnancies and a dilated cervix in the second trimester are at increased risk of pregnancy loss and early preterm birth; there is currently no proven therapy to prevent preterm birth in this group of women. OBJECTIVE: This study aimed to determine whether physical examination-indicated cerclage reduces the incidence of preterm birth in women with a diagnosis of twin pregnancies and asymptomatic cervical dilation before 24 weeks of gestation. STUDY DESIGN: Multicenter, parallel group, open-label, randomized controlled trial of women with twin pregnancies and asymptomatic cervical dilation of 1 to 5 cm between 16 weeks 0/7 days of gestation and 23 weeks 6/7 days of gestation were enrolled from July 2015 to July 2019 in 8 centers. Eligible women were randomized in a 1:1 ratio into either cerclage or no cerclage groups. We excluded women with monochorionic-monoamniotic twin pregnancy, selective fetal growth restriction, twin-twin transfusion syndrome, major fetal malformation, known genetic anomaly, placenta previa, signs of labor, or clinical chorioamnionitis. The primary outcome was the incidence of preterm birth at <34 weeks of gestation. Secondary outcomes were preterm births at <32, <28, and <24 weeks of gestation, interval from diagnosis to delivery, and perinatal mortality. Data were analyzed by intention-to-treat methods. RESULTS: After an interim analysis was performed, the Data and Safety Monitoring Board recommended stopping the trial because of a significant decrease in perinatal mortality in the cerclage group. We randomized 34 women, with 4 women being excluded because of expired informed consent. A total of 17 women were randomized to physical examination-indicated cerclage and 13 women to no cerclage. Whereas 4 women randomized to cerclage did not receive the surgical procedure, no women in the no cerclage group received cerclage. Maternal demographics were not significantly different. All women in the cerclage group also received indomethacin and antibiotics. When comparing the cerclage group vs the no cerclage group, the incidence of preterm birth was significantly decreased as follows: preterm birth at <34 weeks of gestation, 12 of 17 women (70%) vs 13 of 13 women (100%) (risk ratio, 0.71; 95% confidence interval, 0.52-0.96); preterm birth at <32 weeks of gestation, 11 of 17 women (64.7%) vs 13 of 13 women (100%) (risk ratio, 0.65; 95% confidence interval, 0.46-0.92); preterm birth at <28 weeks of gestation, 7 of 17 women (41%) vs 11 of 13 women (84%) (risk ratio, 0.49; 95% confidence interval, 0.26-0.89); and preterm birth at <24 weeks of gestation, 5 of 17 women (30%) vs 11 of 13 women (84%) (risk ratio, 0.35; 95% confidence interval, 0.16-0.75). The mean gestational age at delivery was 29.05±1.7 vs 22.5±3.9 weeks (P<.01), respectively; the mean interval from diagnosis of cervical dilation to delivery was 8.3±5.8 vs 2.9±3.0 weeks (P=.02), respectively. Perinatal mortality was also significantly reduced in the cerclage group compared with the no cerclage group as follows: 6 of 34 women (17.6%) vs 20 of 26 women (77%) (risk ratio, 0.22; 95% confidence interval, 0.1-0.5), respectively. CONCLUSION: In women with twin pregnancies and asymptomatic cervical dilation before 24 weeks of gestation, a combination of physical examination-indicated cerclage, indomethacin, and antibiotics significantly decreased preterm birth at all evaluated gestational ages. Most importantly, cerclage in this population was associated with a 50% decrease in early preterm birth at <28 weeks of gestation and with a 78% decrease in perinatal mortality.
引用
- Roman A, Zork N, Haeri S, et al. Physical examination-indicated cerclage in twin pregnancy: a randomized controlled trial. Am J Obstet Gynecol. 2020. PMID: 32592693. doi:10.1016/j.ajog.2020.06.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。